CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...